We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+11.1%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$292M
AUM Growth
+$16.8M
Cap. Flow
-$7.89M
Cap. Flow %
-2.7%
Top 10 Hldgs %
29.91%
Holding
120
New
8
Increased
27
Reduced
29
Closed
13

Top Buys

Rank Stock Value
1
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$12.2M
2
ARWR icon
Arrowhead Research
ARWR
+$3.01M
3
BIIB icon
Biogen
BIIB
+$2.76M
4
GILD icon
Gilead Sciences
GILD
+$1.62M
5
BIDU icon
Baidu
BIDU
+$1.52M

Top Sells

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.53M
2
CLDX icon
Celldex Therapeutics
CLDX
+$6.14M
3
YHOO
Yahoo Inc
YHOO
+$5.12M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$4.85M
5
NDLS icon
Noodles & Co
NDLS
+$2.64M

Sector Composition

Rank Sector Weight
1 Healthcare 22.95%
2 Energy 16.91%
3 Communication Services 13.82%
4 Industrials 9.86%
5 Consumer Discretionary 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APC
26
DELISTED
Anadarko Petroleum
APC
$4.15M 1.42%
52,345
+425
+0.8% +$38.1K
MMM icon
27
3M
MMM
$89.9B
$4.15M 1.42%
35,396
-221
-0.6% -$23.5K
BIIB icon
28
Biogen
BIIB
$32.3B
$4.1M 1.4%
14,675
+10,675
+267% +$2.76M
TFCFA
29
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$4.1M 1.4%
116,665
+1,050
+0.9% +$35.4K
ARWR icon
30
Arrowhead Research
ARWR
$12B
$4.09M 1.4%
+377,017
New +$3.01M
GOOG icon
31
Alphabet (Google) Class C
GOOG
$4.19T
$4.02M 1.38%
144,178
-191,716
-57% -$4.85M
CNI icon
32
Canadian National Railway
CNI
$76.2B
$3.98M 1.36%
69,840
-1,200
-2% -$66K
TYPE
33
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$3.97M 1.36%
124,665
-250
-0.2% -$7.3K
BAY
34
DELISTED
BAYER AG SPONS ADR
BAY
$3.91M 1.34%
27,553
-296
-1% -$42K
MON
35
DELISTED
Monsanto Co
MON
$3.9M 1.34%
33,485
+12,850
+62% +$1.4M
HCA icon
36
HCA Healthcare
HCA
$90.5B
$3.83M 1.31%
80,375
+32,075
+66% +$1.48M
APL
37
DELISTED
ATLAS PIPELINE PARTNERS LP UTS
APL
$3.81M 1.3%
108,624
+589
+0.5% +$21.5K
PM icon
38
Philip Morris
PM
$299B
$3.79M 1.3%
43,555
+815
+2% +$71.2K
T icon
39
AT&T
T
$178B
$3.66M 1.25%
137,654
+1,920
+1% +$50.5K
GILD icon
40
Gilead Sciences
GILD
$181B
$3.52M 1.21%
46,894
+23,200
+98% +$1.62M
SNY icon
41
Sanofi
SNY
$107B
$3.44M 1.18%
64,075
-550
-0.9% -$28.4K
ESV
42
DELISTED
Ensco Rowan plc
ESV
$3.43M 1.17%
14,983
+170
+1% +$39.2K
CVX icon
43
Chevron
CVX
$396B
$3.4M 1.17%
27,250
-175
-0.6% -$21.2K
UBA
44
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$3.33M 1.14%
180,749
-1,500
-0.8% -$28.8K
KO icon
45
Coca-Cola
KO
$386B
$3.3M 1.13%
79,831
-525
-0.7% -$20.7K
CELG
46
DELISTED
Celgene Corp
CELG
$2.79M 0.95%
33,000
-9,900
-23% -$783K
LMT icon
47
Lockheed Martin
LMT
$130B
$2.67M 0.91%
17,943
-125
-0.7% -$17K
CMCSA icon
48
Comcast
CMCSA
$96B
$2.6M 0.89%
100,200
– –
ABBV icon
49
AbbVie
ABBV
$451B
$2.16M 0.74%
40,900
-100
-0.2% -$4.92K
RL icon
50
Ralph Lauren
RL
$21.1B
$1.94M 0.66%
11,000
+4,000
+57% +$681K
1
2
3 4 5

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Private Capital Advisors held 120 positions worth $292M, up 6.1% from $275M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Private Capital Advisors's Q4 2013 filing shows 8 new, 27 increased, 29 reduced and 13 closed positions. Its largest new stake was SANGAMO THERAPEUTICS INC: 1,059,000 shares worth $14.7M. The largest sale was BioMarin Pharmaceuticals, an estimated $6.53M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

  • Private Capital Advisors's largest Q4 2013 buy was SANGAMO THERAPEUTICS INC: 1,059,000 shares worth $14.7M.
  • Private Capital Advisors added most to Biogen in Q4 2013, an estimated $2.76M increase.
  • Private Capital Advisors's biggest Q4 2013 reduction was Alphabet (Google) Class C, cutting an estimated $4.85M.
  • Private Capital Advisors fully exited BioMarin Pharmaceuticals in Q4 2013, selling an estimated $6.53M.
  • Private Capital Advisors's ten largest holdings make up 30% of its $292M portfolio in Q4 2013.
  • Private Capital Advisors opened 8 new positions and closed 13 in Q4 2013.
  • Private Capital Advisors's portfolio value rose 6.1% quarter-over-quarter to $292M.

Based on Private Capital Advisors's 13F filing for Q4 2013, filed 31 Jan 2014.